Development of genetically engineered human intestinal cells for regulated insulin secretion using rAAV-mediated gene transfer (Q40661144)

22 September 2017

title

Development of genetically engineered human intestinal cells for regulated insulin secretion using rAAV-mediated gene transfer (English)

1 reference

22 September 2017

Shiue-Cheng Tang

1

1 reference

22 September 2017

Athanassios Sambanis

series ordinal

2

1 reference

22 September 2017

publication date

1 April 2003

1 reference

Biochemical and Biophysical Research Communications

22 September 2017

published in

1 reference

22 September 2017

volume

303

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

645-652

1 reference

Glucose regulated production of human insulin in rat hepatocytes

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Regulated hepatic insulin gene therapy of STZ-diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Glucose-regulated insulin expression in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Auto-regulated hepatic insulin gene expression in type 1 diabetic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Novel insulin/GIP co-producing cell lines provide unexpected insights into Gut K-cell function in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Glucose-dependent insulin release from genetically engineered K cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

K cells: a novel target for insulin gene therapy for the prevention of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

A human cellular model for studying the regulation of glucagon-like peptide-1 secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Oxygen consumption rates of free and alginate-entrapped beta TC3 mouse insulinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Use of regulated secretion in protein production from animal cells: an evaluation with the AtT-20 model cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Gastric emptying and release of incretin hormones after glucose ingestion in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Retroviral gene transfer into the intestinal epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Peroral gene therapy of lactose intolerance using an adeno-associated virus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Human glucagon gene promoter sequences regulating tissue-specific versus nutrient-regulated gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Preproinsulin mRNA engineering and its application to the regulation of insulin secretion from human hepatomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Insulin-secreting non-islet cells are resistant to autoimmune destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Cellular characterization of pituitary adenoma cell line (AtT20 cell) transfected with insulin, glucose transporter type 2 (GLUT2) and glucokinase genes: insulin secretion in response to physiological concentrations of glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Insulin-secreting pituitary GH3 cells: a potential beta-cell surrogate for diabetes cell therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Glucose-induced toxicity in insulin-producing pituitary cells that coexpress GLUT2 and glucokinase. Implications for metabolic engineering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

Development and characterization of pituitary GH3 cell clones stably transfected with a human proinsulin cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900399-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-291X(03)00399-1

1 reference

22 September 2017

1 reference